Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Kawata, Takayuki ^a   Daimon, Masao ^a   Hasegawa, Rei ^b   Toyoda, Tomohiko ^b   Sekine, Tai ^c   Himi, Toshiharu ^c   Uchida, Daigaku ^c   Miyazaki, Sakiko ^a   Hirose, Kuniaki ^a   Ichikawa, Ryoko ^a   Maruyama, Masaki ^a   Suzuki, Hiromasa ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c KIMITSU CHUO HOSPITAL   (Japan)

Author keywords

Coronary flow reserve; Diabetes mellitus; Transthoracic doppler echocardiography

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ACUTE CORONARY SYNDROME; ADULT; AREA UNDER THE CURVE; ARTICLE; ASYMPTOMATIC DISEASE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY FLOW RESERVE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; TRANSTHORACIC ECHOCARDIOGRAPHY;

DIABETIC ANGIOPATHIES; ACUTE CORONARY SYNDROME; AGED; ASYMPTOMATIC DISEASES; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84883086369     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-121     Document Type: Article

References (40)

1. Sone H, Tanaka S, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N,. Japan Diabetes Complications Study Group Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endcrinol Metab 2011, 96:3448-3456. Japan Diabetes Complications Study Group.
2. Cortigiani L, Rigo F, Galderisi M, Gherardi S, Bovenzi F, Picano E, Sicari R. Diagnostic and prognostic value of Doppler echocardiographic coronary flow reserve in the left anterior descending artery. Heart 2011, 97:1758-1765. 10.1136/heartjnl-2011-300178, 21835758.
3. Nakanishi K, Fukuda S, Shimada K, Miyazaki C, Otsuka K, Maeda K, Miyahana R, Kawarabayashi T, Watanabe H, Yoshikawa J, Yoshiyama M. Impaired coronary flow reserve as a marker of microvascular dysfunction to predict long-term cardiovascular outcomes, acute coronary syndrome and the development of heart failure. Circ J 2012, 76:1958-1964. 10.1253/circj.CJ-12-0245, 22640984.
4. Rigo F, Gherardi S, Galderisi M, Pratali L, Cortigiani L, Sicari R, Picano E. The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy. Eur Heart J 2006, 27:1319-1323. 10.1093/eurheartj/ehi795, 16464914.
5. Cortigiani L, Rigo F, Gherardi S, Galderisi M, Sicari R, Picano E. Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy. Am J Cardiol 2008, 102:1718-1723. 10.1016/j.amjcard.2008.08.023, 19064030.
6. Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F, Picano E. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007, 50:1354-1361. 10.1016/j.jacc.2007.06.027, 17903635.
7. Hozumi T, Yoshida K, Ogata Y, Akasaka T, Asami Y, Takagi T, Morioka S. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998, 97:1557-1562. 10.1161/01.CIR.97.16.1557, 9593560.
8. Daimon M, Watanabe H, Yamagishi H, Muro T, Akioka K, Hirata K, Takeuchi K, Yoshikawa J. Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography: comparison with exercise thallium-201 single-photon emission computed tomography. J Am Coll Cardiol 2001, 37:1310-1315. 10.1016/S0735-1097(01)01167-6, 11300440.
9. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications 1999, Switzerland, Geneva: World Health Organization, Report of a WHO consultation, World Health Organization.
10. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613-618. 10.1161/01.CIR.55.4.613, 138494.
11. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation 2008, 118:2672-2678. 10.1161/CIRCULATIONAHA.107.743211, 19106389.
12. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. The Action to Control Cardiovascular Risk in Diabetes Study Group.
13. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. The ADVANCE Collaborative Group.
14. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
15. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974, 33:87-94. 10.1016/0002-9149(74)90743-7, 4808557.
16. Feigl EO. Coronary physiology. Physiol Rev 1983, 63:1-205.
17. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attari JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993, 42:1017-1025. 10.2337/diabetes.42.7.1017, 8513969.
18. Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995, 91:635-640. 10.1161/01.CIR.91.3.635, 7828287.
19. Erdogan D, Yucel H, Uysal BA, Ersoy IH, Icli A, Akcay S, Arslan A, Aksoy F, Ozaydin M, Tamer MN. Effect of prediabetes and diabetes on left ventricular and coronary microvascular functions. Metabolism 2013, 62:1123-1130. 10.1016/j.metabol.2013.02.011, 23557591.
20. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906. 10.1161/01.CIR.101.16.1899, 10779454.
21. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101:948-954. 10.1161/01.CIR.101.9.948, 10704159.
22. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 2005, 109:143-159. 10.1042/CS20050025, 16033329.
23. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989, 32:73-97. 10.1016/0033-0620(89)90015-7, 2664879.
24. Picano E. Stress echocardiography, from pathophysiological toy to diagnostic tool. Circulation 1992, 85:1604-1612. 10.1161/01.CIR.85.4.1604, 1555297.
25. Kozàkovà M, Palombo C, Pratali L, Bigalli G, Marzilli M, Distante A, L'Abbate A. Assessment of coronary reserve by transesophageal Doppler echocardiography. Direct comparison between different modalities of dipyridamole and adenosine administration. Eur Heart J 1997, 18:514-523. 10.1093/oxfordjournals.eurheartj.a015274, 9076391.
26. Lim HE, Shim WJ, Rhee H, Kim SM, Hwang GS, Kim YH, Seo HS, Oh DJ, Ro YM. Assessment of coronary flow reserve with transthoracic Doppler echocardiography: comparison among adenosine, standard-dose dipyridamole, and high-dose dipyridamole. J Am Soc Echocardiogr 2000, 13:264-270. 10.1067/mje.2000.103508, 10756243.
27. Matsumura Y, Hozumi T, Watanabe H, Fujimoto K, Sugioka K, Takemoto Y, Shimada K, Muro T, Yoshiyama M, Takeuchi K, Yoshikawa J. Cut-off value of coronary flow velocity reserve by transthoracic Doppler echocardiography for diagnosis of significant left anterior descending artery stenosis in patients with coronary risk factors. Am J Cardiol 2003, 92:1389-1393. 10.1016/j.amjcard.2003.08.042, 14675571.
28. Ragosta M, Powers ER, Samady H, Gimple LW, Sarembock IJ, Beller GA. Relationship between extent of residual myocardial viability and coronary flow reserve in patients with recent myocardial infarction. Am Heart J 2001, 141:456-462. 10.1067/mhj.2001.113074, 11231445.
29. Van Herck PL, Paelinck BP, Haine SE, Claeys MJ, Miljoen H, Bosmans JM, Parizel PM, Vrints CJ. Impaired coronary flow reserve after a recent myocardial infarction: correlation with infarct size and extent of microvascular obstruction. Int J Cardiol 2013, 167:351-356. 10.1016/j.ijcard.2011.12.099, 22244483.
30. Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T, Kaji S, Kawamoto T, Ueda Y, Morioka S. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998, 32:1251-1259. 10.1016/S0735-1097(98)00389-1, 9809933.
31. Kawata T, Daimon M, Hasegawa R, Teramoto K, Toyoda T, Sekine T, Yamamoto K, Uchida D, Himi T, Yoshida K, Komuro I. Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reserve. Heart 2005, 91:1607-1608. 10.1136/hrt.2004.051011, 1769209, 16287749.
32. Shimada K, Watanabe H, Hosoda K, Takeuchi K, Yoshikawa J. Effect of red wine on coronary flow-velocity reserve. Lancet 1999, 354:1002. 10.1016/S0140-6736(99)03478-9, 10501369.
33. Coppola A, Astarita C, Oliviero M, Fontana D, Picardi G, Esposito K, Marfella R, Coppola L, Giugliano D. Impairment of coronary circulation by acute hyperhomocysteinemia in type 2 diabetic patients. Diabetes Care 2004, 27:2055-2056. 10.2337/diacare.27.8.2055, 15277441.
34. Maret E, Engvall J, Nylander E, Ohlsson J. Feasibility and diagnostic power of transthoracic coronary Doppler for coronary flow velocity reserve in patients referred for myocardial perfusion imaging. Cardiovasc Ultrasound 2008, 6:12. 10.1186/1476-7120-6-12, 2292686, 18373873.
35. Snoer M, Monk-Hansen T, Olsen RH, Pedersen LR, Simonsen L, Rasmusen H, Dela F, Prescott E. Insulin resistance and exercise tolerance in heart failure patients: linkage to coronary flow reserve and peripheral vascular function. Cardiovasc Diabetol 2012, 11:97. 10.1186/1475-2840-11-97, 3444364, 22889317.
36. Reinhard H, Wiinberg N, Hansen PR, Kjær A, Petersen CL, Winther K, Parving HH, Rossing P, Jacobsen PK. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis. Cardiovasc Diabetol 2011, 10:71. 10.1186/1475-2840-10-71, 3164620, 21812947.
37. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
38. Gæde P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591. 10.1056/NEJMoa0706245, 18256393.
39. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840. 10.1056/NEJMra061889, 17314342.
40. Boyer JK, Thanigaraj S, Schechtman KB, Pe'rez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004, 93:870-875. 10.1016/j.amjcard.2003.12.026, 15050491.